| # | Title | Journal | Year | Citations |
|---|
| 1 | How mental health care should change as a consequence of the COVID-19 pandemic | Lancet Psychiatry,the | 2020 | 1,101 |
| 2 | Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group | Molecular Psychiatry | 2018 | 522 |
| 3 | Adolescent subthreshold‐depression and anxiety: psychopathology, functional impairment and increased suicide risk | Journal of Child Psychology and Psychiatry and Allied Disciplines | 2013 | 387 |
| 4 | The impact of COVID-19 lockdown on child and adolescent mental health: systematic review | European Child and Adolescent Psychiatry | 2023 | 364 |
| 5 | Updated European Consensus Statement on diagnosis and treatment of adult ADHD | European Psychiatry | 2019 | 330 |
| 6 | Life‐time prevalence and psychosocial correlates of adolescent direct self‐injurious behavior: A comparative study of findings in 11 European countries | Journal of Child Psychology and Psychiatry and Allied Disciplines | 2014 | 298 |
| 7 | Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder | Nature Neuroscience | 2017 | 212 |
| 8 | Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics | JAMA Psychiatry | 2016 | 189 |
| 9 | Psychosocial risk factors for suicidality in children and adolescents | European Child and Adolescent Psychiatry | 2020 | 187 |
| 10 | Bullying Victimization and Suicide Ideation and Behavior Among Adolescents in Europe: A 10-Country Study | Journal of Adolescent Health | 2017 | 167 |
| 11 | Altered structural brain asymmetry in autism spectrum disorder in a study of 54 datasets | Nature Communications | 2019 | 167 |
| 12 | Predictors of outcome in early-onset psychosis: a systematic review | NPJ Schizophrenia | 2015 | 161 |
| 13 | AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders | Nature Communications | 2019 | 150 |
| 14 | Hours of sleep in adolescents and its association with anxiety, emotional concerns, and suicidal ideation | Sleep Medicine | 2014 | 144 |
| 15 | Treatment of negative symptoms: Where do we stand, and where do we go? | Schizophrenia Research | 2017 | 131 |
| 16 | Saving and Empowering Young Lives in Europe (SEYLE): a randomized controlled trial | BMC Public Health | 2010 | 124 |
| 17 | Pathological Internet use among adolescents: Comparing gamers and non-gamers | Psychiatry Research | 2015 | 117 |
| 18 | Bi‐directional longitudinal associations between different types of bullying victimization, suicide ideation/attempts, and depression among a large sample of European adolescents | Journal of Child Psychology and Psychiatry and Allied Disciplines | 2019 | 106 |
| 19 | De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia | Nature Neuroscience | 2020 | 100 |
| 20 | Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis | JAMA Psychiatry | 2021 | 96 |
| 21 | Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis | International Journal of Neuropsychopharmacology | 2017 | 95 |
| 22 | Reduced antioxidant defense in early onset first-episode psychosis: a case-control study | BMC Psychiatry | 2011 | 94 |
| 23 | Magnetic Resonance Imaging and the Prediction of Outcome in First-Episode Schizophrenia: A Review of Current Evidence and Directions for Future Research | Schizophrenia Bulletin | 2015 | 94 |
| 24 | The Promise of Biological Markers for Treatment Response in First-Episode Psychosis: A Systematic Review | Schizophrenia Bulletin | 2015 | 93 |
| 25 | Bitopertin in Negative Symptoms of Schizophrenia—Results From the Phase III FlashLyte and DayLyte Studies | Biological Psychiatry | 2017 | 92 |
| 26 | Lessons Learned From the Coronavirus Health Crisis in Madrid, Spain: How COVID-19 Has Changed Our Lives in the Last 2 Weeks | Biological Psychiatry | 2020 | 90 |
| 27 | Cognitive effects of adjunctive N-acetyl cysteine in psychosis | Psychological Medicine | 2017 | 88 |
| 28 | Pharmacological approaches to treating negative symptoms: A review of clinical trials | Schizophrenia Research | 2013 | 80 |
| 29 | Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features | Psychological Medicine | 2011 | 72 |
| 30 | A quantitative approach to neuropsychiatry: The why and the how | Neuroscience and Biobehavioral Reviews | 2019 | 63 |
| 31 | Suicide prevention for youth - a mental health awareness program: lessons learned from the Saving and Empowering Young Lives in Europe (SEYLE) intervention study | BMC Public Health | 2012 | 62 |
| 32 | Association between victimization by bullying and direct self injurious behavior among adolescence in Europe: a ten-country study | European Child and Adolescent Psychiatry | 2016 | 62 |
| 33 | Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: A 2-year longitudinal study | Schizophrenia Research | 2014 | 59 |
| 34 | Pathological Internet Use Is on the Rise Among European Adolescents | Journal of Adolescent Health | 2016 | 57 |
| 35 | A Neuregulin 1 Variant Is Associated with Increased Lateral Ventricle Volume in Patients with First-Episode Schizophrenia | Biological Psychiatry | 2009 | 54 |
| 36 | Progressive brain changes in children and adolescents with early-onset psychosis: A meta-analysis of longitudinal MRI studies | Schizophrenia Research | 2016 | 54 |
| 37 | Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome | American Journal of Medical Genetics, Part A | 2018 | 51 |
| 38 | Violence among schizophrenia out‐patients compliant with medication: prevalence and associated factors | Acta Psychiatrica Scandinavica | 2009 | 47 |
| 39 | The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for its Methodology and a Review of the Effectiveness of Switching Antipsychotics | Schizophrenia Bulletin | 2015 | 47 |
| 40 | Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure | Schizophrenia Bulletin | 2019 | 47 |
| 41 | Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: Clinical-onset implications | Psychiatry Research | 2010 | 46 |
| 42 | Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patients | European Neuropsychopharmacology | 2013 | 46 |
| 43 | Medically unexplained pain complaints are associated with underlying unrecognized mood disorders in primary care | BMC Family Practice | 2010 | 45 |
| 44 | Early intervention in psychosis: From clinical intervention to health system implementation | Microbial Biotechnology | 2018 | 44 |
| 45 | The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study | European Child and Adolescent Psychiatry | 2017 | 43 |
| 46 | Multi-center MRI prediction models: Predicting sex and illness course in first episode psychosis patients | NeuroImage | 2017 | 43 |
| 47 | BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents | Journal of Psychopharmacology | 2016 | 41 |
| 48 | The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme | Social Psychiatry and Psychiatric Epidemiology | 2020 | 41 |
| 49 | The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis | Journal of Clinical Psychiatry | 2017 | 39 |
| 50 | Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study | Psychological Medicine | 2021 | 38 |
